Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 23;6(2):e28.
doi: 10.2196/resprot.6050.

Rationale and Design of a Genetic Study on Cardiometabolic Risk Factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS)

Maryam S Daneshpour  1 , Mohammad-Sadegh Fallah  1 , Bahareh Sedaghati-Khayat  1 , Kamran Guity  1 , Davood Khalili  2 , Mehdi Hedayati  1 , Ahmad Ebrahimi  1 , Farhad Hajsheikholeslami  2 , Parvin Mirmiran  3 , Fahimeh Ramezani Tehrani  4 , Amir-Abbas Momenan  2 , Arash Ghanbarian  2 , Atieh Amouzegar  5 , Parisa Amiri  6 , Fereidoun Azizi  5
Affiliations

Rationale and Design of a Genetic Study on Cardiometabolic Risk Factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS)

Maryam S Daneshpour et al. JMIR Res Protoc. .

Abstract

Background: Cardiometabolic risk factors comprise cardiovascular diseases and/or diabetes, and need to be evaluated in different fields.

Objective: The primary aim of the Tehran Cardiometabolic Genetic Study (TCGS) is to create a comprehensive genome-wide database of at least 16,000 Tehranians, who are participants of the ongoing Tehran Lipid and Glucose Study (TLGS) cohort.

Methods: TCGS was designed in collaboration with the Research Institute for Endocrine Sciences and the genetic company deCODE. Participants had already been followed for over a 20-year period for major cardiometabolic-related health events including myocardial infarction, stroke, diabetes mellitus, hypertension, obesity, hyperlipidemia, and familial hypercholesterolemia.

Results: The TCGS cohort described here comprises 17,186 (86.3%) of the 19,905 TLGS participants who provided a baseline blood sample that was adequate for plasma and deoxyribonucleic acid analysis. This study is comprised of 849 individuals and 3109 families with at least one member having genotype information. Finally, 5977 males and 7422 females with the total genotyping rate of 0.9854 were genotyped with HumanOmniExpress-24-v1-0 bead chips (containing 649,932 single-nucleotide polymorphism loci with an average mean distance of 4 kilobases).

Conclusions: Investigations conducted within the TCGS will seek to identify relevant patterns of genetic polymorphisms that could be related to cardiometabolic risk factors in participants from Tehran. By linking genome-wide data to the existing databank of TLGS participants, which includes comprehensive behavioral, biochemical, and clinical data on each participant since cohort inception in 1999, the TCGS will also allow exploration of gene-gene and gene-environment interactions as they relate to disease status.

Keywords: cardiometabolic disorders; cardiovascular; genetic; genome-wide association study.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Cohort participation and gender distribution of the study phases.
See this image and copyright information in PMC

References

    1. Beishuizen CR, Stephan BC, van Gool WA, Brayne C, Peters RJ, Andrieu S, Kivipelto M, Soininen H, Busschers WB, Moll van Charante EP, Richard E. Web-based interventions targeting cardiovascular risk factors in middle-aged and older people: a systematic review and meta-analysis. J Med Internet Res. 2016 Mar 11;18(3):e55. doi: 10.2196/jmir.5218. http://www.jmir.org/2016/3/e55/ v18i3e55 - DOI - PMC - PubMed
    1. Mishra SR, Neupane D, Preen D, Kallestrup P, Perry HB. Mitigation of non-communicable diseases in developing countries with community health workers. Global Health. 2015 Nov 10;11:43. doi: 10.1186/s12992-015-0129-5. https://globalizationandhealth.biomedcentral.com/articles/10.1186/s12992... 10.1186/s12992-015-0129-5 - DOI - PMC - PubMed
    1. Islam SM, Purnat TD, Phuong NT, Mwingira U, Schacht K, Fröschl G. Non-communicable diseases (NCDs) in developing countries: a symposium report. Global Health. 2014 Dec 11;10:81. doi: 10.1186/s12992-014-0081-9. https://globalizationandhealth.biomedcentral.com/articles/10.1186/s12992... s12992-014-0081-9 - DOI - PMC - PubMed
    1. World Health Organization . Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva: 2013. [2017-01-26]. http://www.who.int/nmh/events/ncd_action_plan/en/
    1. Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK, American Heart Association Diabetes Committee of the Council on LifestyleCardiometabolic Health‚ Council on Clinical Cardiology‚ Council on CardiovascularStroke Nursing‚ Council on Cardiovascular SurgeryAnesthesia‚ Council on Quality of CareOutcomes Research‚the American Diabetes Association Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2015 Aug 25;132(8):691–718. doi: 10.1161/CIR.0000000000000230. http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=26246173 CIR.0000000000000230 - DOI - PMC - PubMed

LinkOut - more resources